• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    CSafe Global Appoints SVP of Technology and Innovation
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Evotec to Build Second Biologics Mfg. Facility in Toulouse

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    TraceLink Introduces Opus Platform

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Unifying Quality Manufacturing to Drive Speed, Collaboration, and Compliance

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Aphena Pharma Solutions

    Emergent BioSolutions

    Reed-Lane

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    Aphena Pharma Solutions

    Reed-Lane

    Emergent BioSolutions

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Dyadic, Sanofi in Research Collaboration

    To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest

    Related CONTENT
    • Vetio Animal Health
    • Sanofi Restructures Two Global Business Units


    • Pfizer, CYTOO in Research and Option Agreement
    • Aerie Pharma, DSM Biomedical Expand Collaboration
    • 03 Sanofi
    09.18.18
    Dyadic International has entered into a fully funded proof of concept research collaboration to explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest for human health indications with Sanofi-Aventis Deutschland GmbH, a company of the Sanofi group.

    "We are very pleased to have the opportunity to collaborate with Sanofi to express multiple types of important therapeutic compounds using our C1 production platform," said Mark Emalfarb, Dyadic's chief executive officer. "This research and development program is aiming to overcome specific gene expression challenges and to further demonstrate the potential of C1 to become a platform of choice for manufacturing protein-based biologics because of its speed of development and low cost of goods."

    Under the agreement, Sanofi will fund the collaborative research which will utilize the proprietary and patented C1 Gene Expression Platform Technology to express multiple genes for vaccine and drug applications. The research is expected to be completed in the second half of 2019.  Other terms of the research collaboration are confidential.
    Related Searches
    • sanofi
    • collaboration
    • Vaccine
    • production
    Suggested For You
    Vetio Animal Health Vetio Animal Health
    Sanofi Restructures Two Global Business Units

 Sanofi Restructures Two Global Business Units


    Pfizer, CYTOO in Research and Option Agreement Pfizer, CYTOO in Research and Option Agreement
    Aerie Pharma, DSM Biomedical Expand Collaboration Aerie Pharma, DSM Biomedical Expand Collaboration
    03	Sanofi 03 Sanofi
    02	Roche 02 Roche
    09	Gilead Sciences 09 Gilead Sciences
    Kite, Gadeta Enter Collaboration Kite, Gadeta Enter Collaboration
    Sanofi Launches Global R&D Ops in China Sanofi Launches Global R&D Ops in China
    Sanofi Sells European Generics Biz Sanofi Sells European Generics Biz
    Sanofi Appoints EVP, CFO Sanofi Appoints EVP, CFO
    Microbiotica, Genentech Announce Collaboration Microbiotica, Genentech Announce Collaboration
    Beactica Signs Three-Year Extension Agreement With Sanofi Beactica Signs Three-Year Extension Agreement With Sanofi
    Allergan to Acquire Aptinyx Compound  Allergan to Acquire Aptinyx Compound
    RXi Pharma, Iovance Enter Material Transfer Agreement  RXi Pharma, Iovance Enter Material Transfer Agreement

    Related Breaking News

    • Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
      Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

      Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

      To explore synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.
      Kristin Brooks 04.22.21

    • Breaking News | Drug Development | Drug Discovery
      KemPharm Receives $10M Milestone for FDA Approval of Azstarys

      KemPharm Receives $10M Milestone for FDA Approval of Azstarys

      Is eligible to receive an additional near-term $10 million milestone payment following DEA scheduling of SDX.
      Charles Sternberg, Assistant Editor 04.22.21

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

      Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

      Looks to secure a supply agreement for the only inactivated vaccine candidate in clinical trials against COVID-19 in EU.
      Kristin Brooks 04.22.21


    • Biologics, Proteins, Vaccines | Clinical Trials | Trials & Filings
      Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data

      Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data

      VLA2001 was highly immunogenic with more than 90% of study participants developing significant levels of antibodies to SARS-CoV-2 virus spike protein.
      Kristin Brooks 04.22.21

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      AGC Biologics Expands Partnership with Rocket Pharmaceuticals

      AGC Biologics Expands Partnership with Rocket Pharmaceuticals

      AGG will bolster supply across Rocket’s lentiviral vector (LVV) pipeline, with the manufacture of LVV.
      Tim Wright, Editor, Contract Pharma 04.21.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture
      Evotec to Build Second Biologics Mfg. Facility in Toulouse

      Evotec to Build Second Biologics Mfg. Facility in Toulouse

      Evotec's first commercial biomanufacturing facility in Europe is anticipated to deliver much needed capacity for biotherapeutic development and manufacturing.
      Kristin Brooks 04.20.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Resilience Acquires Ology Bioservices

      Resilience Acquires Ology Bioservices

      Continues expansion with acquisition of biologics manufacturing company.
      Tim Wright, Editor, Contract Pharma 04.19.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      RDIF, Hualan Ink COVID-19 Vaccine Deal

      RDIF, Hualan Ink COVID-19 Vaccine Deal

      Deal calls for production of over 100 million doses of Sputnik V vaccine in China.
      Tim Wright, Editor, Contract Pharma 04.19.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

      Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

      EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.
      Tim Wright, Editor, Contract Pharma 04.19.21


    • Breaking News | Drug Development | Industry News
      Evotec Enters Master Service Agreement with Kazia Therapeutics

      Evotec Enters Master Service Agreement with Kazia Therapeutics

      Will work together to make EVT801 available to patients globally.
      Charles Sternberg, Assistant Editor 04.19.21

    • Breaking News | Drug Development | Industry News
      Bristol Myers Squibb Expands at Cambridge Crossing

      Bristol Myers Squibb Expands at Cambridge Crossing

      Adds remaining 113,000 square feet to its initial lease at 250 Water Street.
      Kristin Brooks 04.16.21

    • Breaking News | Drug Development | Industry News
       Amgen Completes Five Prime Acquisition

      Amgen Completes Five Prime Acquisition

      Gains pipeline of immuno-oncology and targeted cancer therapies, including a Phase 3 trial-ready, first-in-class program for gastric cancer.
      Kristin Brooks 04.16.21


    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Sartorius Expands in the UK

      Sartorius Expands in the UK

      New 58,000-square-foot facility aims to simplify and accelerate the production of downstream processing equipment.
      Kristin Brooks 04.16.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Abenza Chooses North Carolina for New Biologics Manufacturing Site

      Abenza Chooses North Carolina for New Biologics Manufacturing Site

      GMP manufacturing will commence in mid-2022.
      Charles Sternberg, Assistant Editor 04.15.21

    • Breaking News | Drug Development | Industry News
      BioVersys Gets EIB Funds to Address Antimicrobial Resistance

      BioVersys Gets EIB Funds to Address Antimicrobial Resistance

      Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumannii
      Kristin Brooks 04.14.21

    Trending
    • Franco Negron Named CEO Of ApiJect Systems America
    • Carton Service Launches Custom Green Packaging Solutions
    • Valneva Focuses On Bilateral Discussions To Supply COVID-19 Vax
    • Thermo Fisher Acquires PPD For $17.4B
    • PRA Health Sciences Expands Pharmacovigilance Services
    Breaking News
    • Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    • KemPharm Receives $10M Milestone for FDA Approval of Azstarys
    • Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax
    • Syneos, Medable Partner for New Decentralized Capabilities
    • CSafe Global Appoints SVP of Technology and Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ashland Supports the Nature Conservancy Forest Restoration Effort to Help Plant a Billion Trees
    Martin Bauer Announces Installation of Agile Filling System at Bethlehem, PA Facility
    PepsiCo and Ingredion Begin Pilot Partnership with Soil and Water Outcomes Fund
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Shareholders Approve Final Dividend at Annual General Meeting
    PPG Maintains EcoVadis Gold Rating
    Sustainable Plastics Will Make Up More Than 15% of Production by 2030
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Getinge Receives FDA Clearance for Multiple Products
    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    TEAM Technologies Acquires ViruDefense
    Contract Pharma

    Latest Breaking News From Contract Pharma

    RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt
    Bora Pharmaceuticals Completes Health Canada Inspection
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Johnson & Johnson Reports Sales Increase in First Quarter of 2021
    THG Launches Recycling Program in UK
    Knoll Printing & Packaging Commits to a Healthy Ocean and Planet
    Happi

    Latest Breaking News From Happi

    L’Oréal Successfully Defends Itself In Patent Infringement Lawsuit
    TFF Names 2021 Honorees for Lifetime Achievement Perfumer and Hall of Fame
    Ashland Donates $20,000 To Help Plant Trees
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    SE-DA Invests in Kornit Presto S
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Ashland commits to forest restoration
    Epson upgrades SurePress demo facility
    Xeikon helps converters navigate toner and inkjet
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Savaré Strengthens Technical Support for the Americas
    FiberVisions, Avgol Partner with Polymateria
    High-Tech Conversions Launches Wipes Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears Orthofix's 3D-Printed FORZA Titanium TLIF Spacer System
    Patients Conclude Clinical Visits in Knee Osteoarthritis Treatment Study
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv, Ameta International Announce US, Canadian Distribution Partnership
    Adesis Achieves ISO 9001:2015 Certification
    Louis Widmer SA Complies with EU Anti-Counterfeiting Directive with Zebra Technologies’ Solution

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login